Matches in Wikidata for { <http://www.wikidata.org/entity/Q69253729> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q69253729 description "article scientifique publié en 1989" @default.
- Q69253729 description "artículu científicu espublizáu n'avientu de 1989" @default.
- Q69253729 description "im Dezember 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69253729 description "scientific article published on 01 December 1989" @default.
- Q69253729 description "wetenschappelijk artikel" @default.
- Q69253729 description "наукова стаття, опублікована в грудні 1989" @default.
- Q69253729 name "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 name "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 type Item @default.
- Q69253729 label "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 label "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 prefLabel "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 prefLabel "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 P1433 Q69253729-C8DC18FA-7465-4910-89DA-EE53752E243F @default.
- Q69253729 P1476 Q69253729-37016BCA-54E8-4645-8FB3-F1576ABBE1C7 @default.
- Q69253729 P2093 Q69253729-0D538C34-84F1-4B32-8097-9E8CC785B4F3 @default.
- Q69253729 P2093 Q69253729-2A0D090C-03CC-486C-ABAD-C9DAFC3852CC @default.
- Q69253729 P2093 Q69253729-2F9E2D9B-E85C-488B-98A9-9CAC8C9C2300 @default.
- Q69253729 P2093 Q69253729-A044D9F2-1586-4CBF-BEFB-462C75561767 @default.
- Q69253729 P2093 Q69253729-C2000B02-EB58-429A-A902-B4699F165BEA @default.
- Q69253729 P2093 Q69253729-C971CBB0-442E-4315-9A68-5951DDA37925 @default.
- Q69253729 P304 Q69253729-AB0F3B23-ED6E-4E82-A9E3-4A327B264DF7 @default.
- Q69253729 P31 Q69253729-1D500FA2-65A4-4D49-9029-F6DBE21690DD @default.
- Q69253729 P356 Q69253729-13F5110D-B029-4AEE-AA4A-65C81AF8696B @default.
- Q69253729 P433 Q69253729-2EE241EE-BC55-47C8-A882-33461C9538E5 @default.
- Q69253729 P478 Q69253729-97C5EC12-D5E2-4E93-BFBF-4549B2EF5118 @default.
- Q69253729 P577 Q69253729-B0A536D9-3E57-494A-B2BD-47B5224B0BDC @default.
- Q69253729 P698 Q69253729-2D653217-8DF6-4540-8A65-931173CBFBB7 @default.
- Q69253729 P921 Q69253729-5E39C4F7-C33C-483F-AC09-36232EAF80AA @default.
- Q69253729 P356 ARCHNEUR.1989.00520480022013 @default.
- Q69253729 P698 2511825 @default.
- Q69253729 P1433 Q15766672 @default.
- Q69253729 P1476 "Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients" @default.
- Q69253729 P2093 "C A Bodian" @default.
- Q69253729 P2093 "D A Moros" @default.
- Q69253729 P2093 "M D Yahr" @default.
- Q69253729 P2093 "M R Mendoza" @default.
- Q69253729 P2093 "S Pang" @default.
- Q69253729 P2093 "T S Elizan" @default.
- Q69253729 P304 "1280-1283" @default.
- Q69253729 P31 Q13442814 @default.
- Q69253729 P356 "10.1001/ARCHNEUR.1989.00520480022013" @default.
- Q69253729 P433 "12" @default.
- Q69253729 P478 "46" @default.
- Q69253729 P577 "1989-12-01T00:00:00Z" @default.
- Q69253729 P698 "2511825" @default.
- Q69253729 P921 Q11085 @default.